1-13 of 13
Authors: Anne Maillard
Journal Article
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 8, August 2024, Pages 1974–1984, https://doi.org/10.1093/jac/dkae194
Published: 17 June 2024
Journal Article
Use of genotypic HIV DNA testing: a DELPHI-type consensus Open Access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 3, March 2024, Pages 578–588, https://doi.org/10.1093/jac/dkae007
Published: 23 January 2024
Journal Article
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 9, September 2021, Pages 2400–2406, https://doi.org/10.1093/jac/dkab193
Published: 07 July 2021
Journal Article
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence? Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 1, January 2020, Pages 183–193, https://doi.org/10.1093/jac/dkz404
Published: 22 October 2019
Journal Article
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1368–1375, https://doi.org/10.1093/jac/dkz021
Published: 20 February 2019
Journal Article
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1417–1424, https://doi.org/10.1093/jac/dkz011
Published: 11 February 2019
Journal Article
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen Free
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 4, April 2018, Pages 1039–1044, https://doi.org/10.1093/jac/dkx511
Published: 12 January 2018
Journal Article
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 8, August 2017, Pages 2351–2354, https://doi.org/10.1093/jac/dkx128
Published: 02 May 2017
Journal Article
Virological failure of patients on maraviroc-based antiretroviral therapy Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 6, June 2015, Pages 1858–1864, https://doi.org/10.1093/jac/dkv026
Published: 19 February 2015
Journal Article
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 5, May 2015, Pages 1507–1512, https://doi.org/10.1093/jac/dku535
Published: 03 January 2015
Journal Article
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 2, February 2015, Pages 566–572, https://doi.org/10.1093/jac/dku419
Published: 25 October 2014
Journal Article
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001–2011 Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 11, November 2013, Pages 2626–2631, https://doi.org/10.1093/jac/dkt238
Published: 24 June 2013
Journal Article
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 12, December 2010, Pages 2620–2627, https://doi.org/10.1093/jac/dkq380
Published: 21 October 2010
